dc.contributor.author |
Rausch, Steffen |
de_DE |
dc.contributor.author |
Kruck, Stephan |
de_DE |
dc.contributor.author |
Stenzl, Arnulf |
de_DE |
dc.contributor.author |
Bedke, Jens |
de_DE |
dc.date.accessioned |
2014-10-07T14:42:19Z |
|
dc.date.available |
2014-10-07T14:42:19Z |
|
dc.date.issued |
2014 |
de_DE |
dc.identifier.issn |
1479-6694 |
de_DE |
dc.identifier.uri |
http://hdl.handle.net/10900/56834 |
|
dc.language.iso |
en |
en |
dc.publisher |
Future Medicine Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.2217/fon.14.61 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
IMA901 for metastatic renal cell carcinoma in the context of new approaches to immunotherapy |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20140813180100_00540 |
de_DE |
utue.publikation.seiten |
937-948 |
de_DE |
utue.personen.roh |
Rausch, Steffen |
de_DE |
utue.personen.roh |
Kruck, Stephan |
de_DE |
utue.personen.roh |
Stenzl, Arnulf |
de_DE |
utue.personen.roh |
Bedke, Jens |
de_DE |
dcterms.isPartOf.ZSTitelID |
Future Oncology |
de_DE |
dcterms.isPartOf.ZS-Issue |
6 |
de_DE |
dcterms.isPartOf.ZS-Volume |
10 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |